Weiyu Zhao

ORCID: 0000-0003-3345-4925
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Interference and Gene Delivery
  • Advanced biosensing and bioanalysis techniques
  • Extraction and Separation Processes
  • CRISPR and Genetic Engineering
  • Radioactive element chemistry and processing
  • Nanoparticle-Based Drug Delivery
  • RNA and protein synthesis mechanisms
  • RNA regulation and disease
  • Geochemistry and Elemental Analysis
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Immune Response and Inflammation
  • ATP Synthase and ATPases Research
  • Chemical Synthesis and Characterization
  • Viral Infectious Diseases and Gene Expression in Insects
  • Monoclonal and Polyclonal Antibodies Research
  • Immune Cell Function and Interaction
  • Folate and B Vitamins Research
  • Nanoplatforms for cancer theranostics
  • Animal Virus Infections Studies
  • Drug Transport and Resistance Mechanisms
  • SARS-CoV-2 and COVID-19 Research
  • Lipid Membrane Structure and Behavior
  • Virus-based gene therapy research
  • Antimicrobial Peptides and Activities

University of Science and Technology Beijing
2022-2024

Tongji University
2024

Shanghai University
2024

Shanghai Maritime University
2024

University of Pittsburgh
2023

University of Bristol
2023

Nanjing University of Information Science and Technology
2023

The Ohio State University
2016-2022

Sichuan University
2021

West China Hospital of Sichuan University
2021

SARS-CoV-2 has become a pandemic worldwide; therefore, an effective vaccine is urgently needed. Recently, messenger RNAs (mRNAs) have emerged as promising platform for vaccination. In this work, the untranslated regions (UTRs) of mRNAs are systematically engineered in order to enhance protein production. Through comprehensive analysis endogenous gene expression and de novo design UTRs, optimal combination 5' 3' UTR identified termed NASAR, which 5- 10-fold more efficient than tested UTRs....

10.1002/adma.202004452 article EN Advanced Materials 2020-09-02

Two-photon excitable (850 nm) NIR fluorescent turn-on (702 probe TP-NIR was synthesized for selective detection of cysteine (Cys). The itself shows is turned on by reaction with Cys in aqueous buffer. In addition, the displays greater selectivity over other thiols, including glutathione (GSH) and homocysteine (Hcy). Moreover, large Stokes shift, excitation, emission make this suitable biological imaging.

10.1021/acssensors.5b00271 article EN ACS Sensors 2016-06-01

<bold>ClO1</bold>, a ratiometric fluorescent probe, effectively captured endogenous HClO in the lungs of lipopolysaccharide (LPS)-induced lung inflammation mouse model after intravenous administration.

10.1039/c8sc03226b article EN cc-by-nc Chemical Science 2018-01-01

Efficient and safe delivery of the CRISPR/Cas system is one key challenges for genome-editing applications in humans. Herein, we designed synthesized a series biodegradable lipidlike compounds containing ester groups mRNA-encoding Cas9. Two lead materials, termed N-methyl-1,3-propanediamine (MPA)-A MPA-Ab, showed tunable rate biodegradation. MPA-A with linear chains was degraded dramatically faster than MPA-Ab branched presence esterase or wild-type mice. Most importantly, demonstrated...

10.1021/acsami.7b08163 article EN ACS Applied Materials & Interfaces 2017-07-07

Abstract Antibodies targeting costimulatory receptors of T cells have been developed for the activation cell immunity in cancer immunotherapy. However, molecule expression is often lacking tumor-infiltrating immune cells, which can impede antibody-mediated Here, we hypothesize that delivery receptor mRNA to will enhance antitumor effects antibodies. We first design a library biomimetic nanoparticles and find phospholipid (PL1) effectively deliver (CD137 or OX40) cells. Then, demonstrate...

10.1038/s41467-021-27434-x article EN cc-by Nature Communications 2021-12-14

Abstract Toll‐like receptors (TLRs) and CD40‐related signaling pathways represent critical bridges between innate adaptive immune responses. Here, an immunotherapy regimen that enables co‐stimulation of TLR7/8‐ CD40‐mediated is developed. TLR7/8 agonist resiquimod (R848) derived amino lipids, RAL1 RAL2, are synthesized formulated into RAL‐derived lipid nanoparticles (RAL‐LNPs). The RAL2‐LNPs show efficient CD40 mRNA delivery to DCs both in vitro (90.8 ± 2.7%) vivo (61.3 16.4%). When combined...

10.1002/adma.202207486 article EN Advanced Materials 2022-09-19

The hot spot extraction agent N,N,N′,N′-tetraoctyl-3-oxoglutaramide (TODGA) has the advantages of novelty, high efficiency and environmental protection in separation rare earths by tandem extraction. In this paper, characteristic parameters for dysprosium, erbium, thulium ytterbium ions TOGDA–kerosene/hydrochloric acid system were calculated. Using a 10% TODGA–kerosene/5 mol·L−1 hydrochloric system, mixture containing Dy3+ 0.258 mol·L−1, Er3+ 0.252 Tm3+ 0.248 Yb3+ 0.242 can be separated...

10.3390/separations11010033 article EN cc-by Separations 2024-01-17

// Cheng-Xiang Zhang 1 , Wei-Yu Zhao Lei Liu Rui-Jun Ju Li-Min Mu Yao Fan Zeng Hong-Jun Xie Yan Wan-Liang Lu Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Natural Biomimetic Drugs, School Pharmaceutical Sciences, Peking University, 100191, China Correspondence to: Lu, e-mail: luwl@bjmu.edu.cn Keywords: Functional targeting epirubicin liposomes, BBB, brain glioblastoma, neovasculatures, mechanism efficacy Received: April 14, 2015 Accepted: September Published:...

10.18632/oncotarget.5354 article EN Oncotarget 2015-09-25

Previously, researchers discovered a series of anti-CRISPR proteins that inhibit CRISPR-Cas activity, such as Cas9 and Cpf1 (Cas12a). Herein, we constructed crRNA variants consisting chemically modified DNA-crRNA RNA-crRNA duplexes identified phosphorothioate (PS)-modified duplex completely blocked the function Cpf1. More important, without prehybridization, these PS-modified DNA oligonucleotides showed ability to suppress double-strand breaks induced by two orthologs, AsCpf1 LbCpf1....

10.1016/j.celrep.2018.11.079 article EN cc-by-nc-nd Cell Reports 2018-12-01
Coming Soon ...